IMPACT OF BASELINE MUTATIONS ON RESPONSE TO PONATINIB AND END OF TREATMENT MUTATION ANALYSIS IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ( PH plus ) LEUKEMIAS

被引:0
作者
Hughes, T. [1 ]
Cortese, J. [2 ]
Kim, D. [3 ]
Nicolini, F. [4 ]
Talpaz, M. [5 ]
Baccarani, M. [6 ]
Mueller, M. [7 ]
Lustgarten, S. [8 ]
Rivera, V. [8 ]
Clackson, T. [8 ]
Turner, C. [8 ]
Haluska, F. [8 ]
Guilhot, F. [9 ]
Hochhaus, A. [10 ]
Goldman, J. [11 ]
Shah, N. [12 ]
Kantarjian, H. [2 ]
Deininger, M. [13 ]
机构
[1] Univ Adelaide, Ctr Canc Biol, SA Pathol, Adelaide, SA, Australia
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[4] Ctr Hosp Lyon Sud, Pierre Benite, France
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] S Orsola Malpighi Univ Hosp, Bologna, Italy
[7] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
[8] ARIAD Pharmaceut Inc, Cambridge, MA USA
[9] CHU Poitiers, INSERM, CIC 0802, Poitiers, France
[10] Univ Klinikum Jena, Jena, Germany
[11] Imperial Coll London, London, England
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P134
引用
收藏
页码:57 / 57
页数:1
相关论文
empty
未找到相关数据